262 related articles for article (PubMed ID: 16131589)
1. The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro.
Westman B; Beeren L; Grudzien E; Stepinski J; Worch R; Zuberek J; Jemielity J; Stolarski R; Darzynkiewicz E; Rhoads RE; Preiss T
RNA; 2005 Oct; 11(10):1505-13. PubMed ID: 16131589
[TBL] [Abstract][Full Text] [Related]
2. Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap.
Yan Y; Svitkin Y; Lee JM; Bisaillon M; Pelletier J
RNA; 2005 Aug; 11(8):1238-44. PubMed ID: 16043507
[TBL] [Abstract][Full Text] [Related]
3. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.
Kentsis A; Topisirovic I; Culjkovic B; Shao L; Borden KL
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18105-10. PubMed ID: 15601771
[TBL] [Abstract][Full Text] [Related]
4. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin targets eIF4E dependent Akt survival signaling.
Tan K; Culjkovic B; Amri A; Borden KL
Biochem Biophys Res Commun; 2008 Oct; 375(3):341-5. PubMed ID: 18706892
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamics of 7-methylguanosine cation stacking with tryptophan upon mRNA 5' cap binding to translation factor eIF4E.
Niedzwiecka A; Stepinski J; Balaspiri L; Darzynkiewicz E; Stolarski R
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1557-61. PubMed ID: 14565465
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamic analysis of mRNA cap binding by the human initiation factor eIF4E via free energy perturbations.
Guimarães CR; Kopecky DJ; Mihalic J; Shen S; Jeffries S; Thibault ST; Chen X; Walker N; Cardozo M
J Am Chem Soc; 2009 Dec; 131(50):18139-46. PubMed ID: 19924990
[TBL] [Abstract][Full Text] [Related]
8. Interaction of three Caenorhabditis elegans isoforms of translation initiation factor eIF4E with mono- and trimethylated mRNA 5' cap analogues.
Stachelska A; Wieczorek Z; Ruszczyńska K; Stolarski R; Pietrzak M; Lamphear BJ; Rhoads RE; Darzynkiewicz E; Jankowska-Anyszka M
Acta Biochim Pol; 2002; 49(3):671-82. PubMed ID: 12422237
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
[TBL] [Abstract][Full Text] [Related]
10. Binding studies of eukaryotic initiation factor eIF4E with novel mRNA dinucleotide cap analogues.
Zuberek J; Jemielity J; Stepinski J; Lewdorowicz M; Niedzwiecka A; Haber D; Stolarski R; Rhoads RE; Darzynkiewicz E
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1703-6. PubMed ID: 14565500
[TBL] [Abstract][Full Text] [Related]
11. Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5' terminus.
Zuberek J; Jemielity J; Jablonowska A; Stepinski J; Dadlez M; Stolarski R; Darzynkiewicz E
Biochemistry; 2004 May; 43(18):5370-9. PubMed ID: 15122903
[TBL] [Abstract][Full Text] [Related]
12. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin?
Galmozzi E; Aghemo A; Colombo M
Med Hypotheses; 2012 Oct; 79(4):471-3. PubMed ID: 22824093
[TBL] [Abstract][Full Text] [Related]
14. Weak binding affinity of human 4EHP for mRNA cap analogs.
Zuberek J; Kubacka D; Jablonowska A; Jemielity J; Stepinski J; Sonenberg N; Darzynkiewicz E
RNA; 2007 May; 13(5):691-7. PubMed ID: 17369309
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes induced in the eukaryotic translation initiation factor eIF4E by a clinically relevant inhibitor, ribavirin triphosphate.
Volpon L; Osborne MJ; Zahreddine H; Romeo AA; Borden KL
Biochem Biophys Res Commun; 2013 May; 434(3):614-9. PubMed ID: 23583375
[TBL] [Abstract][Full Text] [Related]
16. Solution-based approach to study binding to the eIF4E cap-binding site using CD spectroscopy.
Garvie CW
Anal Biochem; 2013 Mar; 434(1):166-71. PubMed ID: 23219983
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence studies on association of human translation initiation factor eIF4E with mRNA cap-analogues.
Wieczorek Z; Niedźwiecka-Kornaś A; Chlebicka L; Jankowska M; Kiraga K; Stepiński J; Dadlez M; Drabent R; Darzynkiewicz E; Stolarski R
Z Naturforsch C J Biosci; 1999; 54(3-4):278-84. PubMed ID: 10349744
[TBL] [Abstract][Full Text] [Related]
18. Exploring tryptamine conjugates as pronucleotides of phosphate-modified 7-methylguanine nucleotides targeting cap-dependent translation.
Golojuch S; Kopcial M; Strzelecka D; Kasprzyk R; Baran N; Sikorski PJ; Kowalska J; Jemielity J
Bioorg Med Chem; 2020 Jul; 28(13):115523. PubMed ID: 32362385
[TBL] [Abstract][Full Text] [Related]
19. Cap-binding protein 1-mediated and eukaryotic translation initiation factor 4E-mediated pioneer rounds of translation in yeast.
Gao Q; Das B; Sherman F; Maquat LE
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4258-63. PubMed ID: 15753296
[TBL] [Abstract][Full Text] [Related]
20. Was the initiation of translation in early eukaryotes IRES-driven?
Hernández G
Trends Biochem Sci; 2008 Feb; 33(2):58-64. PubMed ID: 18242094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
